WallStreetZenWallStreetZen

How to Buy Enliven Therapeutics Stock

Enliven Therapeutics Inc

Enliven Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer.

Enliven Therapeutics stock last closed at $17.18, up 2.38% from the previous day, and has decreased 11.9% in one year. It has overperformed other stocks in the Biotechnology industry by 0.1 percentage points. Enliven Therapeutics stock is currently +75.31% from its 52-week low of $9.80, and -33.92% from its 52-week high of $26.00.

There are currently 41.35M shares of ELVN outstanding. The market value of ELVN is $710.35M. In the last 24 hours, 148,934 ELVN shares were traded.

How to Buy Enliven Therapeutics Stock

Wondering how to invest in Enliven Therapeutics stock? Here's how.
  1. Figure out where to buy Enliven Therapeutics stock: You need to decide on a stock brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you choose where to buy Enliven Therapeutics stock.
  2. Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
  3. Deposit funds into your brokerage account: Select your method of payment and add your details.
  4. Research Enliven Therapeutics stock: The Enliven Therapeutics ticker symbol is ELVN. Is Enliven Therapeutics stock a good investment? Should you buy shares of ELVN? How do ELVN's underlying business fundamentals look? Do top analysts think Enliven Therapeutics is a good buy? Why has ELVN's stock price moved recently? (Hint: Our stock research website can help you decide if ELVN is a good stock to buy).
  5. Execute your ELVN buy order: Decide if you will purchase ELVN shares at the current market price or use a limit order to purchase ELVN stock at a specific price.
  6. Monitor your investment in ELVN: Create a watchlist to the latest updates on your position in Enliven Therapeutics shares.

Step 1: Figure out where to buy Enliven Therapeutics stock

You will need an online brokerage account to access the NASDAQ market and buy ELVN shares.

A brokerage account allows you to buy and sell a number of financial instruments, such as stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

In our opinion, eToro is the best place to buy stocks. Here's why:

  • Invest in stocks with 0% commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
  • Access to global financial markets: From Technology to Industrials, New York to Shanghai — you can fill your portfolio with stocks from the world's leading exchanges.
  • Social investing: eToro has a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other financial assets: Such as ETFs and cryptocurrencies.

Get $10 towards your share purchase by creating an account with eToro today.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open a brokerage account

Now that you've picked the best brokerage, you need to fill out some personal details so you are able to invest in ELVN today.

How to Create a New Investment Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal info to start your new brokerage account.
  1. Submit your information by hitting the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit funds into your brokerage account

Now that you've finished signing up on our top ranked stock app, you can securely and quickly fund your account:

Watch this video walkthrough to see the process of depositing funds into your investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Enliven Therapeutics stock

After you have decided on the best place to buy Enliven Therapeutics stock, it's absolutely critical to analyze their stock before you buy, so you truly understand the risk and opportunity.

Enliven Therapeutics quick stats

ELVN Price
$17.18
1w %
-0.58%
1y %
-11.9%
5y %
N/A
P/E
-8.55x
P/B
2.89x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$71.58M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$710.35M
Next Earnings
Jun 21, 2024
Next Dividend
N/A

ELVN Overview

WallStreetZen was created to help average investors do more in-depth fundamental analysis in less time.

You can see all of the due diligence checks on ELVN's stock page.

How is ELVN stock valued?

Analysts use many financial metrics, analyses, models, and charts to gauge ELVN's true value.

Using relative valuations ratios:

  • ELVN could be undervalued based on its P/B ratio of 2.89x, relative to Biotechnology industry P/B ratio of 5.85x

You can access additional valuation analysis on ELVN's stock here.

ELVN Financial Health Overview

Passed Health Checks:

  • ELVN has cash burn of 61418000. It has sufficient cash and short-term investments to cover this for at least one year.
  • There are more short-term assets than long-term liabilities on the ELVN balance sheet.
  • Total ELVN debt is lower than 5 years ago, relative to shareholder equity.
  • ELVN has $253.20M in cash and short term investments. This is enough to cover its annual cash burn of $61.42M.
  • There are more short-term assets than short-term liabilities on the ELVN balance sheet.
  • ELVN has a low debt to equity ratio of 0.11.

Do Wall Street analysts think it's a good time to buy ELVN stock

Out of 1 Wall Street analysts who monitor ELVN, the consensus analyst rating on ELVN is a Strong Buy

It's important to keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.

You can dig deeper into what analysts are saying on the Enliven Therapeutics stock forecast page.

Metrics for Advanced ELVN Traders

SMA10
17.73
SMA20
18.69
SMA50
17.12
SMA100
15.45
SMA200
15.07
MACD
-0.01
MACD Signal
0.39
MACD Histogram
-0.39
RSI
46.97
Stochastic %K
11.85
Stochastic %D
13.2
StochRSI %K
3.42
StochRSI %D
2.8

Are ELVN executives and large shareholders buying or selling the stock?

In the past 12 months, executives and large shareholders at ELVN have sold more shares than they have bought.

Richard A. Heyman, Director of ELVN, was the latest ELVN insider to sell. They sold $1,654.16 worth of ELVN shares on Apr 15, 2024.

Dig into more about who owns ELVN stock here.

Does ELVN provide a stable income stream?

No, Enliven Therapeutics doesn't provide an income stream by paying out dividends.

What others are saying about ELVN

One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.

Click below to see what other investors have to say.

Step 5: Execute your ELVN buy order

You have two main options:

  • Market order: A market order is an order to buy or sell a stock at the best available price.
    Market orders are usually fine for most investors.
  • Limit order: A limit order lets you buy or sell a security at a specific price (or better).
    If you want to be sure you're buying or selling at an exact dollar amount, place a limit order.

Hit the Open button and your broker will execute your order.

If you want more help buying stocks on eToro, click the helpful video below:

Open eToro Account

Step 6: Monitor your investment in ELVN

Now that you own some ELVN stock, you'll want to stay up-to-date on your new company.

Make a watchlist to get notified of the latest news about your ELVN stock.

ELVN Feed

How to Buy Stock in Enliven Therapeutics

To summarize, here are the 6 steps you need to take to buy Enliven Therapeutics stock right now:

  1. Figure out where to buy Enliven Therapeutics stock
  2. Open a brokerage account
  3. Deposit funds into your brokerage account
  4. Research Enliven Therapeutics stock
  5. Execute your ELVN buy order
  6. Monitor your investment in ELVN

If you require a place to buy stocks, eToro is our recommended option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to keep an eye on your new investment in Enliven Therapeutics, get started below.

NASDAQ: ELVN
$17.18+0.40 (+2.38%)
Updated Apr 26, 2024
Open eToro Account
NASDAQ: ELVN
$17.18+0.40 (+2.38%)
Updated Apr 26, 2024
Open eToro Account

FAQ

How much does it cost to buy one Enliven Therapeutics share?

As of Apr 26, 2024, it costs $17.18 to buy one share of Enliven Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $8, you can buy 0.466 shares of ELVN.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Enliven Therapeutics stock?

According to 1 Wall Street analysts who monitor Enliven Therapeutics, their consensus recommendation is to buy Enliven Therapeutics stock.

What is the best way to buy Enliven Therapeutics stock?

One way to place an order for Enliven Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.